Literature DB >> 15070972

Effect of aldosterone and glycyrrhetinic acid on the protein expression of PAI-1 and p22(phox) in human mononuclear leukocytes.

Lorenzo A Calò1, Francesca Zaghetto, Elisa Pagnin, Paul A Davis, Paola De Mozzi, Paola Sartorato, Giuseppe Martire, Cristina Fiore, Decio Armanini.   

Abstract

Aldosterone excess can produce heart and kidney fibrosis, which seem to be related to a direct effect of aldosterone at the level of specific receptors. We report a direct, mineralocorticoid-mediated effect on the protein expression of two markers of oxidative stress after incubation of mononuclear leukocytes with 1 x 10(-8) M aldosterone (p22(phox)/beta-actin = 1.38 +/- 0.05 and PAI-1/beta-actin = 1.80 +/- 0.05). The same effect was also found with 3 x 10(-5) M glycyrrhetinic acid, the principal constituent of licorice root (p22(phox)/beta-actin = 1.37 +/- 0.97 and PAI-1/beta-actin = 1.80 +/- 0.04). The effect of both aldosterone and glycyrrhetinic acid is blocked by incubation with added 1 x 10(-6) M of receptor-antagonist canrenone. Canrenone alone did not show any effect. PAI-1 related protein was also found using 4 x 10(-9) M aldosterone. Incubations with 1 x 10(-9) M for 3 hours as well as 1 x 10(-8) M aldosterone for 5, 10, and 20 minutes were ineffective for both proteins. These data support the previous finding of an involvement of mononuclear leukocytes in the pathogenesis of the oxidative stress induced by hyperaldosteronism. In addition, the results confirm our previous data on a direct effect of glycyrrhetinic acid at the level of mineralocorticoid receptors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15070972     DOI: 10.1210/jc.2003-031545

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  41 in total

1.  Association of primary aldosteronism with chronic thyroiditis.

Authors:  Chiara Sabbadin; Caterina Mian; Davide Nacamulli; Gabriella Donà; Fabio Presotto; Corrado Betterle; Marco Boscaro; Luciana Bordin; Decio Armanini
Journal:  Endocrine       Date:  2016-02-09       Impact factor: 3.633

2.  Aldosterone and thrombosis formation: implications for ischemic and atherosclerotic heart disease.

Authors:  L A Calò; D Armanini
Journal:  J Endocrinol Invest       Date:  2006 Jul-Aug       Impact factor: 4.256

3.  Licorice abuse: time to send a warning message.

Authors:  Hesham R Omar; Irina Komarova; Mohamed El-Ghonemi; Ahmed Fathy; Rania Rashad; Hany D Abdelmalak; Muralidhar Reddy Yerramadha; Yaseen Ali; Engy Helal; Enrico M Camporesi
Journal:  Ther Adv Endocrinol Metab       Date:  2012-08       Impact factor: 3.565

Review 4.  Phytosteroids beyond estrogens: Regulators of reproductive and endocrine function in natural products.

Authors:  Matthew Dean; Brian T Murphy; Joanna E Burdette
Journal:  Mol Cell Endocrinol       Date:  2016-12-13       Impact factor: 4.102

5.  Idiopathic primary hyperaldosteronism: normalization of plasma aldosterone after one month withdrawal of long-term therapy with aldosterone-receptor antagonist potassium canrenoate.

Authors:  D Armanini; C Scaroni; M J Mattarello; C Fiore; N Albiger; P Sartorato
Journal:  J Endocrinol Invest       Date:  2005-03       Impact factor: 4.256

Review 6.  The emerging role of aldosterone/mineralocorticoid receptors in the pathogenesis of erectile dysfunction.

Authors:  Fei Wu; Yun Lin; Qingyong Liu
Journal:  Endocrine       Date:  2018-05-02       Impact factor: 3.633

7.  Oxidative stress-related proteins in a Conn's adenoma tissue. Relevance for aldosterone's prooxidative and proinflammatory activity.

Authors:  L A Calò; E Pagnin; P A Davis; D Armanini; P Mormino; G P Rossi; A C Pessina
Journal:  J Endocrinol Invest       Date:  2009-07-21       Impact factor: 4.256

Review 8.  The cooperative roles of inflammation and oxidative stress in the pathogenesis of hypertension.

Authors:  Steven D Crowley
Journal:  Antioxid Redox Signal       Date:  2013-04-19       Impact factor: 8.401

Review 9.  Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis.

Authors:  Nancy J Brown
Journal:  Nat Rev Nephrol       Date:  2013-06-18       Impact factor: 28.314

10.  Expression of NAD(P)H oxidase subunits and their contribution to cardiovascular damage in aldosterone/salt-induced hypertensive rat.

Authors:  Young Mee Park; Bong Hee Lim; Rhian M Touyz; Jeong Bae Park
Journal:  J Korean Med Sci       Date:  2008-12-24       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.